41 results on '"Vitola, Eduardo S"'
Search Results
2. The role of glucocorticoid receptor gene in the association between attention deficit-hyperactivity disorder and smaller brain structures
3. T61. CLINICAL, GENETIC AND NEUROIMAGING ASPECTS OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER COURSES THROUGH MIDLIFE
4. Effects of DRD2 splicing-regulatory polymorphism and DRD4 48 bp VNTR on crack cocaine addiction
5. Evidence of sexual dimorphism of HTR1B gene on major adult ADHD comorbidities
6. Further replication of the synergistic interaction between LPHN3 and the NTAD gene cluster on ADHD and its clinical course throughout adulthood
7. Resilience to traumatic events related to urban violence and increased IL10 serum levels
8. Effects of corticotropin-releasing hormone receptor 1 SNPs on major depressive disorder are influenced by sex and smoking status
9. TWO SAMPLE UNIDIRECTIONAL MENDELIAN RANDOMIZATION ANALYSIS BETWEEN WHITE MATTER AND ADHD
10. T59. THE CONNECTION BETWEEN ADHD AND ACADEMIC ACHIEVEMENT IN CONTRASTING ENVIRONMENTS
11. W62. THE IMPACT OF A GENETICALLY PREDICTED DEPRESSION-LIKE TRANSCRIPTOME ON THE COMORBIDITY BETWEEN ATTENTION-DEFICIT HYPERACTIVITY DISORDER AND MAJOR DEPRESSIVE DISORDER
12. Cognitive Deficits in Adults with ADHD Go beyond Comorbidity Effects
13. Does age of onset of impairment impact on neuropsychological and personality features of adult ADHD?
14. Smoking and ADHD: An evaluation of self medication and behavioral disinhibition models based on comorbidity and personality patterns
15. Further evidence for the association between a polymorphism in the promoter region of SLC6A3/DAT1 and ADHD: findings from a sample of adults
16. ADHD Diagnosis May Influence the Association between Polymorphisms in Nicotinic Acetylcholine Receptor Genes and Tobacco Smoking
17. TU1. POLYGENIC RISK SCORE ANALYSES FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER TRAJECTORIES IN ADULTS
18. TH52. REFINING PATTERNS OF MEF2C ASSOCIATIONS WITH WHITE MATTER MICROSTRUCTURE AND PSYCHIATRIC FEATURES
19. NCAM1-TTC12-ANKK1-DRD2 gene cluster and the clinical and genetic heterogeneity of adults with ADHD
20. Erratum to: Further evidence for the association between a polymorphism in the promoter region of SLC6A3/DAT1 and ADHD: findings from a sample of adults
21. Late-onset ADHD in adults: Milder, but still dysfunctional
22. MR and GR functional SNPs may modulate tobacco smoking susceptibility
23. Adrenergic α2A receptor gene is not associated with methylphenidate response in adults with ADHD
24. Could comorbid bipolar disorder account for a significant share of executive function deficits in adults with attention-deficit hyperactivity disorder?
25. T5THE USE OF PRS ANALYSIS TO VALIDATE THE PARTIAL ADHD SYNDROME
26. INFLUENCE OF NICOTINIC RECEPTOR GENE – CHRNA5 – ON CRACK COCAINE DEPENDENCE AND SEVERITY
27. F1NEUROIMAGING GENETICS OF REMISSION AND PERSISTENCE IN ADULTHOOD ADHD
28. EXOCYTOSIS-RELATED GENE-SETS AND RESPONSE TO METHYLPHENIDATE TREATMENT IN ADULTS WITH ADHD
29. Effects of DRD2 splicing-regulatory polymorphism and DRD4 48 bp VNTR on crack cocaine addiction
30. M113 - INFLUENCE OF NICOTINIC RECEPTOR GENE – CHRNA5 – ON CRACK COCAINE DEPENDENCE AND SEVERITY
31. M84 - EXOCYTOSIS-RELATED GENE-SETS AND RESPONSE TO METHYLPHENIDATE TREATMENT IN ADULTS WITH ADHD
32. Severity But Not Comorbidities Predicts Response to Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder
33. ADHD Diagnosis May Influence the Association between Polymorphisms in Nicotinic Acetylcholine Receptor Genes and Tobacco Smoking
34. Could comorbid bipolar disorder account for a significant share of executive function deficits in adults with attention‐deficit hyperactivity disorder?
35. The role of a lifetime history of oppositional defiant and conduct disorders in adults with ADHD: implications for clinical practice
36. Cognitive Deficits in Adults With ADHD Go Beyond Comorbidity Effects
37. Adrenergic α2A receptor gene is not associated with methylphenidate response in adults with ADHD
38. Reasons for Pretreatment Attrition and Dropout From Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder
39. NCAM1‐TTC12‐ANKK1‐DRD2gene cluster and the clinical and genetic heterogeneity of adults with ADHD
40. Reasons for Pretreatment Attrition and Dropout From Methylphenidate in Adults With Attention - Deficit/Hyperactivity Disorder The Role of Comorbidities
41. Response to methylphenidate treatment among adults with ADHD according to comorbidity status.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.